Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

about

Thrombosis, platelets, microparticles and PAH: more than a clot.Advances in inhaled technologies: understanding the therapeutic challenge, predicting clinical performance, and designing the optimal inhaled product.The trials and hopes for drug development in sickle cell disease.

P2860

Q35276116-9325272A-17AB-477D-973B-335715C36995 Q38185862-3FF09B2C-834A-43C1-8FB6-C5C6D3EA456E Q38540335-21DECA31-6E79-4586-949E-F4A8BA4B5E10

P2860

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q37944298

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@en

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@nl

type

Item

label

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@en

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@nl

prefLabel

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@en

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@nl

P1476

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

@en

P2093

Matthew Ferrantino

http://www.w3.org/2001/XMLSchema#string

R James White

http://www.w3.org/2001/XMLSchema#string

P2860

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

Updated clinical classification of pulmonary hypertension.

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

Inhaled iloprost for severe pulmonary hypertension.

Pulmonary arterial hypertension in France: results from a national registry.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.

Prostacyclin and its analogues in the treatment of pulmonary hypertension.

Cellular and molecular pathobiology of pulmonary arterial hypertension.

P304

2583-2593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.622269

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21988216

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

about

P2860

P2860

Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921